Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1

PHASE2TerminatedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Complex Regional Pain Syndrome, Type I
Interventions
DRUG

lenalidomide

Two 5 mg capsules taken one time per day

DRUG

Placebo

Two placebo capsules taken one time per day

Trial Locations (27)

10003

Hospital for Joint Disease, New York

14642

University of Rochester Medical Center, Rochester

18103

Lehigh Valley Hospital, Allentown

19034

Knobler Institute of Neurologic Disease, Fort Washington

19102

Drexel University College of Medicine Department of Neurology Rm 7102, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

22903

University of Virginia Pain Management Center, Charlottesville

27103

Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC, Winston-Salem

27705

Duke University Medical Center, Durham

28310

Womack Army Medical Center, Fort Bragg

32905

Space Coast Neurology, Palm Bay

45432

Research Institute of Greater Dayton, Dayton

52242

University of Iowa, Iowa City

55905

Mayo Clinic, Rochester

60611

Rehab Institute of Chicago, Chicago

63141

Washington University Pain Mgmt Ctr, St Louis

75390

University of Texas Southwestern Medical Center, Dallas

79430

Texas Tech Medical Center Department of Anesthesiology, Lubbock

85381

Pivotal Research Centers, Peoria

92093

UCSD Center for Pain and Palliative Medicine, La Jolla

92354

Loma Linda Institution, Loma Linda

97239

Oregon Health & Science University, Portland

98104

Swedish Pain Services, Seattle

60611-2908

Northwestern University, Chicago

02115

Beth Israel Deaconess Medical Center, Boston

01199

Baystate Medical Center, Springfield

27599-7010

UNC Hospitals University of North Carolina, Chapel Hill

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY